| Scorecard |
|---|
|
3 / 5 Stars
|
|
Lipper
3
4
2
1
4
|
|
Zacks Investment Research
5
(Strong Sell)
|
|
Standard & Poor's
3 / 5 Stars
|
|
TheStreet.com
D
(Sell)
|
Fund Holdings
Asset Allocation
| % Long | % Short | % Net | |
|---|---|---|---|
| Cash | 1.87 | 1.11 | 0.76 |
| Stocks | 1.42 | 0.0 | 1.42 |
| Bonds | 0.0 | 0.0 | 0.0 |
| Other | 0.0 | 0.0 | 0.0 |
| Foreign Bonds | 0.0 | 0.0 | 0.0 |
| Foreign Stocks | 97.82 | 0.0 | 97.82 |
| Convertible | 0.0 | 0.0 | 0.0 |
| Preferred | 0.0 | 0.0 | 0.0 |
Updated 04.30.2013
Top 10 Holdings
Performance as of 05.31.2013
Portfolio as of 04.30.2013
| Ticker | YTD Return % | % Net Assets | |
|---|---|---|---|
| Roche Holding AG | RHHVF | 21.67 | 4.62 |
| Sanofi | SAN | --- | 3.07 |
| Orix Corporation | ORXCF | 43.25 | 2.39 |
| Novartis AG | NVSEF | 14.18 | 2.31 |
| Barclays PLC ADR | BCS | 14.61 | 2.19 |
| Nestle SA | NSRGF | 0.68 | 2.13 |
| Syngenta AG | SYENF | 36.94 | 2.1 |
| Eni SpA | ENI | --- | 2.01 |
| Swiss Re AG | SREN | --- | 1.96 |
| Diageo PLC | DGE | --- | 1.93 |
